No Stock Yet
GENPF GENIX PHARMACEUTICALS CORPORATION
0.0660.0000.00%
YOY
Do not show
(Q1)2023/01/31(FY)2022/10/31(Q4)2022/10/31(Q3)2022/07/31
Financial Ratios
Efficiency Ratios TTM
Receivable Turnover（T）
--
0.2002
--
--
--
--
--
--
Fixed Assets Turnover（T）
--
0.1122
--
--
--
--
--
--
Total Asset Rate（T）
--
0.0004
--
--
--
--
--
--
ROIC
29.44%
-26.339%
22.67%
-28.531%
22.67%
-28.531%
54.64%
-30.086%
ROE
24.85%
-28.334%
20.07%
-29.779%
20.07%
-29.779%
53.75%
-31.151%
ROA
33.45%
-22.148%
27.12%
-23.809%
27.12%
-23.809%
53.05%
-25.810%
Efficiency Ratios
ROE 5 Year Average
--
--
14.94%
-79.265%
--
--
--
--
ROA 5 Year Average
--
--
17.26%
-32.279%
--
--
--
--
Average 5 Years ROIC
--
--
21.85%
-50.421%
--
--
--
--
Profitability Ratios TTM
Operating Margin
--
-58758.091%
--
--
--
--
--
--
Net Margin
--
-60843.173%
--
--
--
--
--
--
EBITDA Margin
--
-242.2162%
--
--
--
--
--
--
R & D Expense Ratio
--
0.000%
--
--
--
--
--
--
Sales Expense Ratio
--
0.000%
--
--
--
--
--
--
Administration Expense Rate
--
21168.650%
--
--
--
--
--
--
Financial Health Ratios
Total Assets to Common Equity
17.91%
139.885%
11.88%
132.933%
11.88%
132.933%
6.54%
124.914%
Debt to Asset Ratio
874.69%
11.155%
367.89%
5.705%
367.89%
5.705%
1,425.61%
5.527%
Current Ratio
78.26%
0.239
-9.77%
0.2281
-9.77%
0.2281
-51.59%
0.145
Quick Ratio
-45.52%
0.042
-87.33%
0.0245
-87.33%
0.0245
-71.86%
0.0718
GrowthRatios
Growth Ratios
Currency Unit
CADCADCADCAD
FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.
Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%
Company Overview
More
CEO： Mr. Sina Salehi Pirooz
Market： Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist